Skip Navigation



Carcinogenesis Advance Access published online on May 19, 2005

Carcinogenesis, doi:10.1093/carcin/bgi126
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
26/10/1741    most recent
bgi126v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gu, J.
Right arrow Articles by Wu, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gu, J.
Right arrow Articles by Wu, X.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oupjournals.org
Received December 20, 2004
Revised May 3, 2005
Accepted May 10, 2005

MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

Roles of tumor suppressor and telomere maintenance genes in cancer and aging - an epidemiological study

Jian Gu 1, Margaret R. Spitz 1, Hua Zhao 1, Jie Lin 1, H. Barton Grossman 2, Colin P. Dinney 2, and Xifeng Wu 1*

1 Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas
2 Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas

* To whom correspondence should be addressed.
Xifeng Wu, E-mail: xwu{at}mdanderson.org


   Abstract

Advanced age is strikingly linked to increased incidence of cancer. To gain insight into the mechanism underlying the association between increased cancer incidence and aging in normal human physiological conditions, we used a case-control design and measured the mRNA expression levels of p53, ATM, hTERT, and TRF2, four major protectors of genomic integrity, in isolated peripheral blood lymphocytes from 202 confirmed bladder cancer (BC) patients and 199 healthy controls. Significant age effects on expression levels were observed. When we divided the study subjects into three age groups (<57, 57 to 65, and ≥65), the expressions of p53, ATM, and TRF2 significantly decreased with advancing age in cases (P for trend ≤0.001, 0.01 and 0.01 for p53, ATM, and TRF2, respectively). In controls, however, p53 expression significantly increased with advancing age (P for trend = 0.05). Among subjects ≥65 years old, the expressions of p53, ATM, and TRF2 was significantly lower in cases than in controls (P = 0.003, 0.04, and 0.05 for p53, ATM, and TRF2, respectively), suggesting that attenuated genomic maintenance mechanisms lead to increased cancer risk in older individuals. When we dichotomized our study population at the median age of study subjects (61 years old), low p53 expression was associated with a significantly increased BC risk in older people (OR = 2.27, 95% CI = 1.00 - 5.16). In addition, older subjects without detectable hTERT expression had a significantly reduced BC risk (OR = 0.41, 95% = 0.17 - 0.99). Our study provides the first epidemiologic evidence that the increased genomic instability resulting from the combination of telomere dysfunction, impaired ATM- and p53-mediated DNA damage, and/or telomere dysfunction response pathway contributes to increased cancer incidence in the elderly population.

Keywords: cancer; aging; p53; ATM; mRNA expression; telomere dysfunction.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
K. R. Poynter, P. C. Sachs, A. T. Bright, M. S. Breed, B. N. Nguyen, L. W. Elmore, and S. E. Holt
Genetic inhibition of telomerase results in sensitization and recovery of breast tumor cells
Mol. Cancer Ther., May 1, 2009; 8(5): 1319 - 1327.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Woelfelschneider, O. Popanda, C. Lilla, J. Linseisen, C. Mayer, O. Celebi, J. Debus, H. Bartsch, J. Chang-Claude, and P. Schmezer
A distinct ERCC1 haplotype is associated with mRNA expression levels in prostate cancer patients
Carcinogenesis, September 1, 2008; 29(9): 1758 - 1764.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. Wang, M. R. Spitz, H. Yang, C. Lu, D. J. Stewart, and X. Wu
Genetic Variants in Cell Cycle Control Pathway Confer Susceptibility to Lung Cancer
Clin. Cancer Res., October 1, 2007; 13(19): 5974 - 5981.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
U. P. Kodavanti, M. C. Schladweiler, A. D. Ledbetter, R. V. Ortuno, M. Suffia, P. Evansky, J. H. Richards, R. H. Jaskot, R. Thomas, E. Karoly, et al.
The Spontaneously Hypertensive Rat: An Experimental Model of Sulfur Dioxide-Induced Airways Disease
Toxicol. Sci., November 1, 2006; 94(1): 193 - 205.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.